دورية أكاديمية
Health Care Utilization Following Inpatient Femoropopliteal Revascularization With Drug-Coated Balloon Angioplasty: A Nationwide Cohort Analysis.
| العنوان: | Health Care Utilization Following Inpatient Femoropopliteal Revascularization With Drug-Coated Balloon Angioplasty: A Nationwide Cohort Analysis. |
|---|---|
| المؤلفون: | Gurin MI; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., Beyer SE; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., Weinberg M; Division of Cardiology, Department of Medicine, Northwell Health, New York, NY, USA., Parikh SA; Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA., Armstrong EJ; UCHealth Heart and Vascular Center, Aurora, CO, USA., Albaghdadi MS; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Aronow HD; Lifespan Cardiovascular Institute, Rhode Island and The Miriam Hospitals, Providence, RI, USA., Carroll BJ; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., Yeh R; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., Secemsky EA; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA. |
| المصدر: | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists [J Endovasc Ther] 2021 Apr; Vol. 28 (2), pp. 246-254. Date of Electronic Publication: 2021 Jan 11. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Sage Publications Country of Publication: United States NLM ID: 100896915 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-1550 (Electronic) Linking ISSN: 15266028 NLM ISO Abbreviation: J Endovasc Ther Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2015- : Thousand Oaks, CA : Sage Publications Original Publication: Phoenix, AZ : The Society, c2000- |
| مواضيع طبية MeSH: | Angioplasty, Balloon*/adverse effects , Cardiovascular Agents*/adverse effects , Peripheral Arterial Disease*/diagnostic imaging , Peripheral Arterial Disease*/therapy , Pharmaceutical Preparations*, Coated Materials, Biocompatible ; Cohort Studies ; Femoral Artery/diagnostic imaging ; Humans ; Inpatients ; Paclitaxel ; Patient Acceptance of Health Care ; Popliteal Artery/diagnostic imaging ; Prospective Studies ; Time Factors ; Treatment Outcome ; Vascular Patency |
| مستخلص: | Purpose: To examine nationwide variations in inpatient use of drug-coated balloons (DCBs) for treating femoropopliteal segment occlusive disease and whether DCBs are associated with reduced early out-of-hospital health care utilization. Materials and Methods: The study included 24,022 patients who survived hospitalization for femoropopliteal revascularization using DCB angioplasty (n=7850) or uncoated balloon angioplasty (n=16,172) in the 2016-2017 Nationwide Readmissions Database. Differences in patient, hospitalization, and institutional characteristics were compared between treatment strategies. Adjusted logistic regression models were used to examine differences in 6-month rates of readmission, amputation, and repeat intervention. Results are presented as the odds ratio (OR) and 95% confidence interval (CI). Results: Patients treated with DCBs had a higher prevalence of chronic limb-threatening ischemia, diabetes, hypertension, and tobacco use. Revascularization with a DCB was associated with shorter hospitalizations, lower median hospitalization costs, and fewer inpatient lower extremity amputations. Readmissions at 6 months were decreased in patients treated with DCBs compared with uncoated balloon angioplasty (OR 0.90, 95% CI 0.83 to 0.98, p=0.014). The most common reasons for readmission were complications related to procedures (15.4%) and diabetes (15.4%). Compared to patients treated with DCBs, patients treated with uncoated balloon angioplasty were more often readmitted with early procedure-related complications (13.3% vs 17.5%). There were no between-group differences in readmission for sepsis, myocardial infarction, or congestive heart failure. Conclusion: DCBs are less often used compared to uncoated balloons during inpatient femoropopliteal procedures. While DCB utilization is associated with more severe comorbidities and advanced peripheral artery disease, readmission rates are decreased through the first 6 months. |
| فهرسة مساهمة: | Keywords: amputation; balloon angioplasty; chronic limb-threatening ischemia; critical limb ischemia; drug-coated balloon; femoropopliteal segment; percutaneous transluminal angioplasty; peripheral artery disease; readmission; reintervention; revascularization; stenosis |
| المشرفين على المادة: | 0 (Cardiovascular Agents) 0 (Coated Materials, Biocompatible) 0 (Pharmaceutical Preparations) P88XT4IS4D (Paclitaxel) |
| تواريخ الأحداث: | Date Created: 20210111 Date Completed: 20210624 Latest Revision: 20210624 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1177/1526602820984111 |
| PMID: | 33426984 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1545-1550 |
|---|---|
| DOI: | 10.1177/1526602820984111 |